Liquid profiling enabled by Viennalab

ViennaLab is now releasing the first real-time PCR assay for monitoring lung cancer patients eligible to the alternative treatment with Osimertinib (Tagrisso) due to acquired resistance to EGFR-tyrosine kinase inhibitor (TKI) therapy: EGFR T790M RealFast Assay.
For proper sample preparation, ViennaLab is offering a column-based Plasma cfDNA Extraction Kit allowing isolation of high-purity circulating cell-free DNA from fresh or frozen human plasma.
The kits are available now!